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Species Differences in the
Metabolism of Benzene
Rogene F. Henderson
Inhalation Toxicology Research Institute, Albuquerque, New Mexico
The pathways of metabolism of benzene appear to be qualitatively similar in all species studied
thus far. However, there are quantitative differences in the fraction of benzene metabolized by
the different pathways. These species differences become important for risk assessments based
on animal data. Mice have a greater overall capacity to metabolize benzene than rats or primates,
based on mass balance studies conducted in vivo using radiolabled benzene. Mice and monkeys
metabolize more of the benzene to- hydroquinone metabolites than do rats or chimpanzees,
especially at low doses. Nonhuman primates metabolize less of the benzene to muconic acid
than do rodents or humans. In all species studied, a greater proportion of benzene is converted to
hydroquinone and ring-breakage metabolites at low doses than at high doses. This finding should
be considered in attempting to extrapolate the toxicity of benzene observed at high doses to
predicted toxicity at low doses. Because ring-breakage metabolites and hydroquinone have both
been implicated in the toxicity of benzene, the higher formation of those metabolites in the
mouse may partially explain why mice are more sensitive to benzene than are rats. Metabolism
of benzene in humans, the species of interest, does not exactly mimic that of any animal
species studied. More information on the urinary and blood metabolites of occupationally
exposed people is required to determine the fractional conversion of benzene to putative toxic
metabolites and the degree of variability present in human subjects. Environ Health Perspect
104(Suppl 6):1173-1175 (1996)
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Introduction
Two-year bioassay studies ofthe toxicity of
benzene indicated that B6C3F1 mice
develop more and more varied tumors in
response to similar benzene exposures than
do Sprague-Dawley rats (1,2). To deter-
mine ifspecies differences in metabolism of
benzene contribute to species differences in
response to benzene, studies have been
conducted comparing metabolism of ben-
zene in rats and mice and comparing the
rodent metabolism to that in primates,
including humans. This paper reviews
many ofthose studies.
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Studies using radiolabeled benzene deter-
mined the mass balance ofbenzene in the
bodyofdifferent species following exposures
by various routes and to a range ofdoses
(3-8). The questions addressed by the
studies were a) How much of benzene
administered by inhalation, intraperitoneally
or orally is absorbed and metabolized by
different species? b) What is the ultimate
fate of the absorbed benzene-in which
tissues or excreta and in what form?
c) How does total dose affect the answers
to the first two questions?
Species Differences in
Absorption and Total
Metabolism of Benzene
Mice have a higher capacity to metabolize
benzene than either rats or cynomolgus
monkeys (6,7). After 6-hr exposures to low
concentrations (7-10 ppm) ofbenzene,
mice retained 20% of the benzene they
inhaled compared to 3 to 4% for rats or
monkeys. This fact, plus the higher respira-
tory rate per body weight in the mice,
results in mice receiving approximately
twice the internal dose as rats after short-
term exposures to concentrations of ben-
zene up to about 150 to 200 ppm (Table
1) (9,10). At higher exposure concentra-
tions, metabolism becomes saturated in
both species, but particularly in the mouse.
A 7-fold increase in the exposure concen-
tration (from 130 to 925 ppm) results in
only about a 3-fold increase in internal dose
in the mouse, and 15% of the absorbed
dose is exhaled as unmetabolized benzene
(Table 1). Nonetheless, the mouse metabo-
lizes a greater fraction (85%) ofits internal
dose of 152 mg/kg than the rat, which was
only able to metabolize about halfits inter-
nal dose of 116 mg/kg (7,9) following
exposure to 925 ppm. If the dose is not
delivered slowly over a 6-hr period as in
the inhalation studies but is given as a
bolus dose, either orally or by intraperi-
toneal injection, only about halfof a dose
of 150 mg/kg is metabolized by either
species, and the other half is exhaled as
unmetabolized benzene. Even a bolus dose
of 50 mg/kg results in an increase in the
fractional amount ofexhaled benzene over
what is observed at lower doses in both rats
and mice (3,4).
Species Differences in
Excretion Patterns
The pattern ofexcretion ofthe internal dose
ofbenzene is similar in the rat and mouse,
with most ofthe dose excreted in the urine
(Table 1). A small amount is found in feces,
a small amount remains in the body, and, at
low exposure concentrations, only a small
fraction is exhaled unmetabolized. In
exposed monkeys, the mass balance was not
complete because the animals were not
killed at the end ofthe exposures to deter-
mine the remaining body burdens and
Table 1. Internal dose and subsequent excretion pathways in rats and mice exposed to [14C]benzene.a
Exposure Internal dose, Excretion pathways, % initial dose
concentration, mg/kg Urine Feces Exhaled air Carcass
ppm Rats Mice Rats Mice Rats Mice Rats Mice Rats Mice
11 3.3 7.5 91 88 3 8 4 3 2 1
130 24 60 88 89 2 3 5 1 5 7
925 116 152 48 79 3 5 48 15 1 1
"Exposures were for 6 hr atthe indicated concentrations; excreta were collected for 48 hr afterthe exposure.
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exhaled breath was not collected; therefore,
there is not a complete accounting ofall of
the radioactivity of the benzene adminis-
tered to monkeys (6). However, the data
we have suggest that the monkey does not
have a high capacity to metabolize benzene.
Monkeys dosed intraperitoneally with 5, 50
or 500 mg [14C]benzene/kg excreted only
56, 37, and 13% ofthe radioactivity in the
urine, respectively, suggesting that the
monkey's capacity to metabolize benzene is
exceeded at relatively low doses. On the
other hand, chimpanzees administered 1
mg/kg of [14C]benzene intravenously
excreted essentially all ofthe radioactivity
in the urine.
Because most of the internal dose in
animals exposed to low doses of benzene
appears to be excreted as metabolites in the
urine, one can get a picture ofthe overall
metabolism ofbenzene in these animals by
observing the metabolic profile in the
urine. The urinary profiles in benzene-
exposed mice, rats, and primates are shown
in Table 2. For the low-dose treatments, a
major species difference between rats and
mice is the higher fraction ofbenzene con-
verted to hydroquinone and its conjugates
Table 2. Urinary metabolites (% of total) following
exposure to [14C]benzene.
Exposure concentration,
6 hr, ppm
Mice
Phenyl conjugates
Hydroquinone conjugates
Pre-PMA
Muconic acid
Rats
Phenyl conjugates
Hydroquinone conjugates
Pre-PMA
Muconic acid
Monkey
Phenyl conjugates
Hydroquinone conjugates
Catechol conjugates
Pre-PMA
Muconic acid
Chimpanzee
Phenyl conjugates
Hydroquinone conjugates
Catechol conjugates
Pre-PMA
Muconic acid
in the mice. The urine ofthe monkeys, on
the other hand, contains approximately the
same fraction ofhydroquinone as found in
the urine ofmice. One must keep in mind,
however, that a smaller fraction ofinhaled
benzene is metabolized in the monkey com-
pared to the mouse. The urinary profile of
the chimpanzee is similar to that ofthe rat
in regard to the hydroquinone fraction.
A second species difference is that
rodents (both rats and mice) metabolize
more of the benzene to ring-breakage
metabolites (as indicated by muconic acid)
than primates (Table 2). Finally, one obser-
vation is consistent for all species studied. A
smaller fraction ofthe benzene is converted
to hydroquinone and ring-breakage
metabolites at higher doses than at low
doses (3,7,8). A possible reason for the
lower fractions ofhydroquinone produced
at higher benzene exposures has been sug-
gested by Schlosser et al. (11), who found
that high levels of benzene inhibit the
metabolism of phenol. However, the
mechanism by which the fraction ofring-
breakage metabolites produced at high
benzene doses is decreased is not known.
Species Differences in Blood,
Bone Marrow, and Other
Tissue Concentrations of
Benzene Metabolites
5 50 600 It is important to know if the metabolic
profile in the urine matches that in the
37 37 67a blood and in the major target tissue for
33 40 la benzene, the bone marrow. The profile of
6 1 15a benzene metabolites found in the bone
23 21 5a marrow ofrats versus mice following a 6-hr
exposure to 50 ppm benzene is shown in
158 723 72a Table 3 (8). The major metabolites found
12 31 17a in the bone marrow ofrats are phenyl con-
19 14 48 jugates or muconic acid. (Catechol conju-
gates were not separated from phenyl
IPdose, mg/kg conjugates in this study.) Hydroquinone
5 50 500 conjugates were detected only in the mouse
61 73 78b bone marrow and not in the rat. Muconic
27 15 9b acid concentrations were also higher in the
8 0 6 0 9.9 mouse than in the rat.
4.4 3.1 1.3b
IV dose
1 mg/kg
75
8
0.5
5.5
Table 3. Benzene metabolites in bone marrow of
rodentsa(% oftotal).
B6C3F1 mice F344 rats
Hydroquinone glucuronide 23 ND
Muconic acid 12 4
Phenyl glucuronide 1.5 ND
Phenyl or catechol sulfate 63 96
ND, not detected. aExposures from 6 hr to 50 ppm ben-
zene. From Sabourin etal. (8)andHenderson et al. (9).
Blood, liver, and lung levels ofbenzene
metabolites in rats and mice were calculated
as the "area under the curve," i.e., the inte-
grated dose of the metabolite during and
following a 6-hr exposure to 50 ppm ben-
zene (Table 4) (8,9). Hydroquinone conju-
gates could not be detected in the blood or
tissues of rats but were equal to or about
halfthe level ofphenyl conjugates in mice.
Muconic acid levels were especially high in
mouse livers. Thus, the urinary profiles of
benzene metabolites were similar to those
found in the tissues ofthe rodents.
Recent research by McDonald et al.
(12) indicates that the formation of 1,2-
benzoquinone protein adducts in the blood
and bone marrow of benzene-exposed
rodents is favored in rats, while the forma-
tion of 1,4-benzoquinone adducts is
favored in mice. The authors suggest that
this is due to the higher amounts of
epoxide hydrolase activity compared to
cytochrome P450 activity in the livers of
rats compared to those ofmice. The higher
fractions of benzene converted to hydro-
quinone in mice versus rats would predict a
higher amount of the 1,4-benzoquinone
being formed in the mouse. In rats, how-
ever, we do not have evidence for a large
amount of catechol formation, and cate-
chol would be the expected precursor for
1,2-benzoquinone formation.
In studies using liver microsomes (11),
the percent ofbenzene converted to phenol
was about 20% in both rat and mouse
microsomes, but the fraction of benzene
converted to hydroquinone was 31% in the
mouse compared to 8% in the rat.
Conversion to catechol was 0.5% in the rat
and 2% in the mouse liver microsomes,
while very little muconic acid was formed
in either species. These data are consistent
with the higher formation ofhydroquinone
in mice versus rats in in vivo studies but
Table 4. Benzene metabolites in F344 rats and B6C3F1
mice exposed to 50 ppm benzene for 6 hr(X ± SE) (area
underthe curve, nmol/g/hr).
Hydroquinone Muconic Phenyl
conjugates acid conjugates
Blood
Rats NDa 4.3± 2.5 144 ±32
Mice 105 ± 14 8.0 ± 5.5 225±49
Liver
Rats ND 65± 10 93 29
Mice 190 ± 31 1200 95 150 34
Lung
Rats ND 14±3 112 15
Mice 110±17 110±13 230±37
"ND, not detected. From Henderson et al. (9).
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contrasts with the high level of muconic
acid found in livers ofmice exposed in vivo.
The study by Schlosser et al. (11) also pre-
dicted that most ofthe catechol formed in
either the rat or the mouse comes from oxi-
dation ofphenol rather than hydrolysis of
benzene oxide. This was based on the fact
that the same amount of catechol was
formed in rodent liver microsome incuba-
tions whether the substrate was benzene or
phenol. The conclusion that most of the
catechol comes from phenol contrasts with
the conclusion of McDonald et al. (12),
who suggested that the preponderance of
1,2- over 1,4-benzoquinone adducts in ben-
zene-exposed rats compared to mice is due
to the higher rate offormation ofcatechol
via hydrolysis ofbenzene oxide in the rat.
The quantitative contribution of the two
pathways for catechol formation in the two
species remains to be elucidated.
Summary and Discussion
The pathways of metabolism of benzene
appear to be qualitatively similar in all
species studied thus far. However, there are
quantitative differences in the fraction of
benzene metabolized by the different path-
ways. Mice appear to have a greater overall
capacity to metabolize benzene than rats or
primates, based on mass balance studies
conducted in vivo using radiolabeled ben-
zene. Mice and monkeys metabolize more
ofthe benzene to hydroquinone metabolites
than do rats or chimpanzees, especially at
low doses. Nonhuman primates metabolize
less ofthe benzene to muconic acid than do
rodents or humans. Because ring-breakage
metabolites and hydroquinone have both
been implicated in the toxicity ofbenzene,
the higher formation ofthese metabolites in
the mouse may partially explain why mice
are more sensitive to benzene toxicity than
are rats. Mice also metabolize more of
inhaled benzene than do rats.
For all species studied, there is a greater
fractional formation of these and ring-
breakage metabolites at low doses com-
pared to high doses. This also appears to be
true for humans (Bechtold et al., unpub-
lished data). This finding, along with
many other factors, must be considered in
attempting to extrapolate the toxicity of
benzene observed at high doses to those
expected at low doses.
Metabolism ofbenzene in humans, the
species of interest, does not exactly mimic
that of any animal species studied. More
information on the urinary and blood
metabolites ofoccupationally exposed peo-
ple is required to determine the fractional
conversion of benzene to putative toxic
metabolites and the degree ofvariability
present in the human subjects.
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